Cyclerion Therapeutics, Inc. · NASDAQ:CYCN
Peter M. Hecht converted 351,037 Cyclerion Therapeutics, Inc. shares (Form 4)
Traded Jul 16, 2026 · Filed Jul 20, 2026
On Jul 16, 2026, Peter M. Hecht (Director, 10% owner) converted 351,037 Cyclerion Therapeutics, Inc. shares, leaving 910,240 shares. Filed Jul 20, 2026 (Form 4).
- Converted
- 351,037 shares
- Holding after
- 910,240 shares
- Trading plan
- No
- Role
- Director, 10% owner
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jul 16, 2026 | Common Stock | Conversion | 351,037 | 910,240 | Direct |
Source
Related
- Cyclerion Therapeutics, Inc.
- Peter M. Hecht
- Cyclerion Therapeutics, Inc. shareholders
- Form 4 · Chicko Rhonda M. · Aug 18, 2026
- Form 4 · Graul Regina Margaret · Aug 18, 2026
- Schedule 13G · ADAR1 Capital Management, LLC · Aug 14, 2026
- Schedule 13G · Balyasny Asset Management L.P. · Aug 14, 2026
- Schedule 13D/A · Peter M. Hecht · Jul 20, 2026